Edition:
United Kingdom

Sunesis Pharmaceuticals Inc (SNSS.OQ)

SNSS.OQ on NASDAQ Stock Exchange Capital Market

2.51USD
23 May 2018
Change (% chg)

$-0.27 (-9.71%)
Prev Close
$2.78
Open
$2.77
Day's High
$2.83
Day's Low
$2.48
Volume
27,429
Avg. Vol
50,208
52-wk High
$7.68
52-wk Low
$1.84

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.24 -0.212
FY 2017 Dec '17 0.00 -0.209
Sep '17 0.00 -0.429
Jun '17 0.00 -0.411
Mar '17 0.67 -0.468
FY 2016 Dec '16 0.68 -0.442
Sep '16 0.61 -0.617
Jun '16 0.61 -0.721
Mar '16 0.64 -0.698
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 4 0.21 0.60 0.00 8.30
Quarter Ending Sep-18 4 0.15 0.60 0.00 8.30
Year Ending Dec-18 5 0.64 2.00 0.20 9.02
Year Ending Dec-19 4 0.73 2.40 0.00 2.00
Earnings (per share)
Quarter Ending Jun-18 4 -0.23 -0.21 -0.26 -0.49
Quarter Ending Sep-18 4 -0.22 -0.16 -0.25 -0.49
Year Ending Dec-18 5 -0.86 -0.70 -0.98 -1.60
Year Ending Dec-19 4 -0.99 -0.70 -1.16 -1.50
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.06 32.75
P/E High - Last 5 Yrs. -- 293.32 45.73
P/E Low - Last 5 Yrs. -- 91.63 24.23
Beta 1.38 0.90 0.88
Price to Sales (TTM) 28.99 110.95 5.71
Price to Book (MRQ) -- 13.58 5.37
Price to Tangible Book (MRQ) 4.54 14.04 6.94
Price to Cash Flow (TTM) -- 71.44 23.33
% Owned Institutions 68.49 12.71 2.16

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) -- 15.72 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 399.27 9.21
Sales (TTM) vs TTM 1 Yr. Ago -24.89 78.86 5.69
Sales - 5 Yr. Growth Rate -12.70 32.18 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago 43.00 25.14 19.38
EPS (TTM) vs TTM 1 Yr. Ago 32.89 -- --
EPS - 5 Yr. Growth Rate -- 39.01 10.77
Capital Spending - 5 Yr. Growth Rate -- 40.31 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.81 2.19
Current Ratio (MRQ) 3.37 5.29 2.98
LT Debt to Equity (MRQ) 43.49 22.98 12.17
Total Debt to Equity (MRQ) 56.85 24.63 16.44
Interest Coverage (TTM) -32.04 -99.39 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.04 54.45
Gross Margin - 5 Yr. Avg. -- 51.16 52.21
EBITD Margin (TTM) -1,771.92 -- --
EBITD - 5 Yr. Avg -811.88 -575.09 10.96
Operating Margin (TTM) -1,772.38 -718.94 4.73
Operating Margin - 5 Yr. Avg. -812.40 -596.41 6.40
Pre-Tax Margin (TTM) -1,849.97 -693.40 5.57
Pre-Tax Margin - 5 Yr. Avg. -851.74 -599.76 6.82
Net Profit Margin (TTM) -1,849.97 -694.62 1.87
Net Profit Margin - 5 Yr. Avg. -851.74 -602.62 3.09
Effective Tax Rate (TTM) -- 22.63 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.22 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) 52,838 22,637,573 847,034,055
Net Income/Employee (TTM) -977,486 2,973,815 99,640,144
Receivable Turnover (TTM) -- 20.17 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) 0.07 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -122.85 -1.09 10.95
Return on Assets - 5 Yr. Avg. -78.71 -0.58 12.32
Return on Investment (TTM) -174.35 1.57 14.38
Return on Investment - 5 Yr. Avg. -154.42 2.21 16.11
Return on Equity (TTM) -- 2.43 16.07
Return on Equity - 5 Yr. Avg. -430.12 3.09 17.39
  1 Year 3 Year 5 Year
Sales % -17.15 -31.69 -12.70
EPS (TTM) % 19.67 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Sunesis Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 74.50%
# of Holders: 64
Total Shares Held: 25,605,169
3 Mo. Net Change: -278,700
# New Positions: 15
# Closed Positions: 5
# Increased Positions: 28
# Reduced Positions: 14
# Net Buyers: 14
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.